成人接种Priorix®疫苗后不同应答类型的转录组谱分析
研究纳入童年已接种过麻疹/腮腺炎/风疹(MMR)疫苗的健康成人,第0天接种一剂Priorix®,依据第0、21、150和365天抗体滴度变化划分4种应答组,并在第0、3、7天用3'mRNA测序分析转录组。结果显示差异表达基因数量有限,多数为免疫相关且在第3、7天较基线上调;抗体滴度和转录组数据表明额外接种一剂Priorix®并不能使针对3种病毒的免疫应答均等,个体间亦不均等。
要点
- 依据第0、21、150、365天抗体滴度变化,成人接种一剂Priorix®后可分为4种应答组。
- 第3、7天差异表达基因数量有限,多数为免疫相关基因且较第0天上调。
- 抗体与转录组数据表明额外接种一剂Priorix®不能使3种病毒或不同受种者获得均等免疫应答。
核心结论
- 额外接种一剂Priorix®不能使针对麻疹、腮腺炎、风疹3种病毒的免疫应答均等,也不同受种者间均等。
- 短期基因表达谱与不同抗体应答组相关,差异表达基因有限但多数为免疫相关且在第3、7天上调。
研究设计与样本
- 健康成人志愿者童年已接种过MMR抗原,本研究第0天接种一剂Priorix®。
- 依据第0、21、150和365天抗体滴度演变定义4种应答组。
- 第0、3、7天采用3'mRNA测序测定转录组谱。
- 采用「每个时间点一个应答组」和「每个应答组内时间比较」两种分析方式。
主要发现
- 抗体滴度在个体内和个体间均显示高度变异性。
- 差异表达基因列表有限,但多数为免疫相关基因,且第3、7天较基线第0天上调。
- 依应答组不同,3种病毒中有2种存在重叠的特征性表达谱。
- 抗体滴度与转录组数据表明额外接种一剂Priorix®不能使3种病毒或不同受种者获得均等免疫应答。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Thanks to the recommendation of a combined Measles/Mumps/Rubella (MMR) vaccine, like Priorix®, these childhood diseases are less common now. This is beneficial to limit the spread of these diseases and work towards their elimination. However, the measles, mumps and rubella antibody titers show a large variability in short- and long-term immunity. The recent outbreaks worldwide of measles and mumps and previous studies, which mostly focused on only one of the three virus responses, illustrate that there is a clear need for better understanding the immune responses after vaccination. Our healthy cohort was already primed with the MMR antigens in their childhood. In this study, the adult volunteers received one Priorix® vaccine dose at day 0. First, we defined 4 different groups of responders, based on their antibody titers' evolution over 4 time points (Day 0, 21, 150 and 365). This showed a high variability within and between individuals. Second, we determined transcriptome profiles using 3'mRNA sequencing at day 0, 3 and 7. Using two analytical approaches, "one response group per time point" and "a time comparison per response group", we correlated the short-term gene expression profiles to the different response groups. In general, the list of differentially expressed genes is limited, however, most of them are clearly immune-related and upregulated at day 3 and 7, compared to the baseline day 0. Depending on the specific response group there are overlapping signatures for two of the three viruses. Antibody titers and transcriptomics data showed that an additional Priorix vaccination does not facilitate an equal immune response against the 3 viruses or among different vaccine recipients.
引用
- Bartholomeus E, De Neuter N, Suls A, et al. Transcriptomic profiling of different responder types in adults after a Priorix® vaccination. Vaccine. 2020. PMID: 32165045. doi:10.1016/j.vaccine.2020.03.004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。